World's Best Scientists 2026 revealed!
Maryalice Stetler-Stevenson

Maryalice Stetler-Stevenson

D-Index & Metrics

Medicine

D-Index
90
Citations
38289
World Ranking
12040
National Ranking
6174

Maryalice Stetler-Stevenson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Maryalice Stetler-Stevenson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 369 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Maryalice Stetler-Stevenson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Maryalice Stetler-Stevenson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Maryalice Stetler-Stevenson is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on medical sciences with a significant emphasis on oncology, pathology and forensic medicine, genetics, immunology, and hematology.

Their work spans several subfields of study, including:

  • Oncology
  • Pathology and Forensic Medicine
  • Genetics
  • Immunology
  • Hematology

The scientist's main topics of research encompass:

  • CAR-T cell therapy research
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Viral-associated cancers and disorders
  • Immunodeficiency and Autoimmune Disorders

Maryalice Stetler-Stevenson has contributed to numerous peer-reviewed papers. Notable recent publications include:

  • CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial, 2020, Journal of Clinical Oncology
  • Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL, 2021, Journal of Clinical Oncology
  • Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells, 2021, Blood
  • Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells, 2022, Blood Advances
  • Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib, 2020, Blood

The scientist frequently collaborates with a select group of co-authors, including:

  • Constance M. Yuan
  • Hao-Wei Wang
  • Irina Marić
  • Seth M. Steinberg
  • Nirali N. Shah

Publication venues where Maryalice Stetler-Stevenson's work appears most often include:

  • Blood
  • Journal of Clinical Oncology
  • Blood Advances
  • JAMA Oncology
  • British Journal of Haematology

Best Publications

  • T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

    Daniel W Lee;James N Kochenderfer;Maryalice Stetler-Stevenson;Yongzhi K Cui

  • Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor

    James N. Kochenderfer;Mark E. Dudley;Sadik H. Kassim;Robert P.T. Somerville

  • B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

    James N. Kochenderfer;Mark E. Dudley;Steven A. Feldman;Wyndham H. Wilson

  • Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

    James N. Kochenderfer;Wyndham H. Wilson;John E. Janik;Mark E. Dudley

  • CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.

    Terry J Fry;Nirali N Shah;Rimas J Orentas;Maryalice Stetler-Stevenson

  • ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

    Adrian Wiestner;Andreas Rosenwald;Todd S. Barry;George Wright

  • The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

    Yair Herishanu;Patricia Pérez-Galán;Delong Liu;Angélique Biancotto

  • Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

    Richard L. Piekarz;Robin Frye;Maria Turner;John J. Wright

  • T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

    Syed Abbas Ali;Victoria Shi;Irina Maric;Michael Wang

  • T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

    Jennifer N. Brudno;Irina Maric;Steven D. Hartman;Jeremy J. Rose

  • Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

    Waleed Haso;Daniel W. Lee;Nirali N. Shah;Maryalice Stetler-Stevenson

  • Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia

    Robert J. Kreitman;Wyndham H. Wilson;Karen Bergeron;Miranda Raggio

  • Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies.

    Robert J. Kreitman;Wyndham H. Wilson;Jeffrey D. White;Maryalice Stetler-Stevenson

  • IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells.

    Steven A. Rosenberg;Claude Sportès;Mojgan Ahmadzadeh;Terry J. Fry

  • Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

    Michail S. Lionakis;Kieron Dunleavy;Mark Roschewski;Brigitte C. Widemann

  • In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

    Liliana Guedez;William G. Stetler-Stevenson;Linda Wolff;Jiun Wang

  • Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.

    Mohammed Z H Farooqui;Janet Valdez;Sabrina Martyr;Georg Aue

  • High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.

    Upendra Hegde;Armando Filie;Richard F. Little;John E. Janik

  • Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275

    Gurmeet Kaur;Maryalice Stetler-Stevenson;Sandra Sebers;Peter Worland

  • A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

    M C Sneller;S E Straus;E S Jaffe;J S Jaffe

Frequent Co-Authors

Robert J. Kreitman
Robert J. Kreitman National Cancer Institute
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Ola Landgren
Ola Landgren University of Miami
Mark Raffeld
Mark Raffeld National Institutes of Health
Wyndham H. Wilson
Wyndham H. Wilson National Institutes of Health
Ira Pastan
Ira Pastan Center for Cancer Research
Terry J. Fry
Terry J. Fry University of Colorado Denver
Gerald E. Marti
Gerald E. Marti National Institutes of Health
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Diane C. Arthur
Diane C. Arthur National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Medicine but seeking alternative or complementary fields, a diverse range of online healthcare degrees can open new career doors. Many healthcare roles do not require a traditional MD, yet still offer meaningful and in-demand opportunities within the industry.

A popular choice is pursuing a master's in healthcare administration online, preparing graduates for leadership roles in hospitals, clinics, and healthcare organizations. Another advanced path is enrolling in the cheapest dnp programs online, which can lead to top clinical or academic nursing positions without attending a brick-and-mortar university.

Those interested in pharmacy can now earn a pharmacy degree online, combining flexibility with a solid foundation for pharmacy practice. Meanwhile, students with a passion for data and technology may pursue rhit programs online, paving the way for careers in health information management.

Each of these online degree pathways provides affordable, accessible options for those looking to make an impact in healthcare—either alongside or instead of medical school.

Best Scientists Citing Maryalice Stetler-Stevenson

Trending Scientists

Recently Published Articles